June 16, 2025

Updated Guidance on Antirheumatic Drug Use

New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.

Conexiant

June 12, 2025

Medical Oddities: 6 Foot Moves Possibly Worth Prescribing

Strong feet, smarter carbs, test kits, and tea—this roundup’s got range.

Conexiant

June 12, 2025

Gene Variants Linked to CPPD Risk

A large genetic study in U.S. veterans has identified ENPP1 and RNF144B as genes associated with calcium pyrophosphate deposition disease, suggesting potential for targeted treatment approaches.

Conexiant

June 12, 2025

Circulating miR-126-3p Linked to Knee OA

Plasma levels of miR-126-3p are elevated in radiographic knee osteoarthritis and may attenuate disease severity by reducing angiogenesis.

Conexiant

June 12, 2025

DMARD Therapy Linked to Less Pain Sensitivity

Improvements in pressure pain thresholds were associated with reductions in disease activity.

Conexiant

June 06, 2025

Shifting Views Linked to Fewer Joint Surgeries, Study 

A Swedish study found that patients with knee or hip osteoarthritis who became unwilling to have joint replacement after a 3-month education and exercise program were significantly less likely to undergo surgery over the next several years.

Conexiant

June 03, 2025

Stopping Antipsychotics May Lower Risks Posthospitalization: Study

Older adults who stopped antipsychotic medications after hospitalization had fewer rehospitalizations, less delirium, and lower mortality, according to a large U.S. study using real-world Medicare data.

Conexiant

June 02, 2025

Glycosylated IgG Disrupts Kidney Cell Metabolism: Study 

Children with lupus nephritis had altered IgG sugar chains that impaired kidney cell metabolism, and removing those sugars reversed the injury in lab tests.

Conexiant

June 02, 2025

Only 20% Account for 80% of Steroid Use: Study

In a UK-wide analysis of nearly 2 million patients, researchers found that “a fifth of patients receiving corticosteroids accounted for over 80% of oral and inhaled corticosteroid prescribing,” highlighting concentrated use and variable treatment persistence across formulations.

Conexiant